Your browser doesn't support javascript.
loading
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.
Podadera-Herreros, Alicia; Arenas-de Larriva, Antonio P; Gutierrez-Mariscal, Francisco M; Alcala-Diaz, Juan F; Ojeda-Rodriguez, Ana; Rodriguez-Cantalejo, Fernando; Cardelo, Magdalena P; Rodriguez-Cano, Diego; Torres-Peña, Jose D; Luque, Raul M; Ordovas, Jose M; Perez-Martinez, Pablo; Delgado-Lista, Javier; Lopez-Miranda, Jose; Yubero-Serrano, Elena M.
Afiliación
  • Podadera-Herreros A; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Arenas-de Larriva AP; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Gutierrez-Mariscal FM; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
  • Alcala-Diaz JF; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Ojeda-Rodriguez A; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
  • Rodriguez-Cantalejo F; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Cardelo MP; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
  • Rodriguez-Cano D; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Torres-Peña JD; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
  • Luque RM; Biochemical Laboratory, Reina Sofia University Hospital, 14004, Córdoba, Spain.
  • Ordovas JM; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Perez-Martinez P; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
  • Delgado-Lista J; Biochemical Laboratory, Reina Sofia University Hospital, 14004, Córdoba, Spain.
  • Lopez-Miranda J; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.
  • Yubero-Serrano EM; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Nutr Diabetes ; 14(1): 27, 2024 05 16.
Article en En | MEDLINE | ID: mdl-38755195
ABSTRACT

BACKGROUND:

Type 2 diabetes mellitus (T2DM) is recognized an independent risk factor for chronic kidney disease (CKD). The precise contribution and differential response to treatment strategies to reduce kidney dysfunction, depending on whether obesity is present alongside T2DM or not, remain to be fully clarified. Our objective was to improve our understanding of how obesity contributes to kidney function in patients with T2DM and coronary heart disease (CHD), who are highly predisposed to CKD, to assign the most effective dietary approach to preserve kidney function.

METHODS:

1002 patients with CHD and estimated glomerular filtration rate (eGFR)≥30 ml/min/1.73m2, were randomized to consume a Mediterranean diet (35% fat, 22% MUFA, < 50% carbohydrates) or a low-fat diet (28% fat, 12% MUFA, > 55% carbohydrates). Patients were classified into four groups according to the presence of T2DM and/or obesity at baseline Non-Obesity/Non-T2DM, Obesity/Non-T2DM, Non-Obesity/T2DM and Obesity/T2DM. We evaluated kidney function using serum creatinine-based estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR) before and after 5-years of dietary intervention.

RESULTS:

Patients with Obesity/T2DM had the lowest baseline eGFR and the highest baseline uACR compared to non-diabetics (p < 0.05). After dietary intervention, the Mediterranean diet induced a lower eGFR decline in patients with Obesity/T2DM, compared to a low-fat diet but not in the other groups (p = 0.014). The Mediterranean diet, but not the low-fat diet, also reduced uACR only in patients with Obesity/T2DM (p = 0.024).

CONCLUSIONS:

Obesity provided an additive effect to T2DM resulting in a more pronounced decline in kidney function compared to T2DM alone when compared to non-diabetics. In patients with concomitant presence of T2DM and obesity, with more metabolic complications, consumption of a Mediterranean diet seemed more beneficial than a low-fat diet in terms of preserving kidney function. These findings provide valuable insights for tailoring personalized lifestyle modifications in secondary prevention of cardiovascular disease. TRIAL REGISTRATION URL, http//www.cordioprev.es/index.php/en . CLINICALTRIALS gov number, NCT00924937.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Dieta Mediterránea / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Tasa de Filtración Glomerular / Riñón / Obesidad Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nutr Diabetes Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Coronaria / Dieta Mediterránea / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Tasa de Filtración Glomerular / Riñón / Obesidad Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nutr Diabetes Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido